1-fluoro-10-iododecane | CAS:512783-29-8

We serve 1-fluoro-10-iododecane CAS:512783-29-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
1-fluoro-10-iododecane

Chemical Name:1-fluoro-10-iododecane
CAS.NO:512783-29-8
Synonyms:1-fluoro-10-iododecane
Decane, 1-fluoro-10-iodo-
Molecular Formula:C10H20FI
Molecular Weight:286.172 
 
Physical and Chemical Properties:
Density:1.3±0.1
Boiling point:283.7±8.0ºC
Flash point:283.7±8.0ºC
Index of Refraction:1.477
 
Specification:
Appearance:Colorless transparent liquid
Assay:≥99.0%
Moisture:≤0.05%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Organic synthesis intermediate



Contact us for information like 1-fluoro-10-iododecane chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Decane, 1-fluoro-10-iodo- physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-fluoro-10-iododecane Use and application,1-fluoro-10-iododecane technical grade,usp/ep/jp grade.


Related News: Another prominent coronavirus to emerge since the turn of the century is Middle East respiratory syndrome (MERS), which was first identified in Saudi Arabia in 2012 and killed more than 800 people.3-Iodo-1-propanol acetate manufacturer The move could force international drugmakers to further cut prices and enable copycat medicines to replace imported off-patent brands at faster pace.p-toluidine supplier Three more patients have been confirmed infected with coronavirus in South Korea, bringing the country’s total to 15, the South Korean Centers for Disease Control and Prevention (KCDC) announced in a press release.2,4-Difluorobenzyl Alcohol vendor European companies are the main suppliers of specialty APIs, but due to environmental and cost pressures, APIs have begun to shift to the Asian market.Beta Bionics is a for-profit Massachusetts public benefit corporation founded in 2015 to commercialize the iLet, a revolutionary bionic pancreas that is driven by mathematical dosing algorithms, which incorporate lifelong autonomous learning to automatically control glycemia.